Compare ONON & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ONON | BIO |
|---|---|---|
| Founded | 2010 | 1952 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Shoe Manufacturing | Biotechnology: Laboratory Analytical Instruments |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.4B | 10.1B |
| IPO Year | 2021 | 1994 |
| Metric | ONON | BIO |
|---|---|---|
| Price | $34.46 | $354.88 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 31 | 3 |
| Target Price | $43.98 | ★ $335.00 |
| AVG Volume (30 Days) | ★ 10.6M | 219.5K |
| Earning Date | 11-11-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 142.61 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,583,200,000.00 |
| Revenue This Year | $16.62 | N/A |
| Revenue Next Year | $19.00 | $2.13 |
| P/E Ratio | $56.05 | ★ N/A |
| Revenue Growth | N/A | ★ 0.65 |
| 52 Week Low | $26.37 | $236.73 |
| 52 Week High | $51.08 | $396.23 |
| Indicator | ONON | BIO |
|---|---|---|
| Relative Strength Index (RSI) | 63.31 | 41.26 |
| Support Level | $31.52 | $284.88 |
| Resistance Level | $38.73 | $391.87 |
| Average True Range (ATR) | 1.03 | 11.89 |
| MACD | 0.15 | -1.84 |
| Stochastic Oscillator | 72.36 | 18.72 |
Founded in Switzerland in 2010, sportswear firm On Holding generates more than 90% of its sales from athletic shoes. The brand is best known for its running shoes and its distinctive CloudTec soles. On also produces athletic apparel (6% of 2025 sales) and accessories (1%). The firm's merchandise is available in more than 80 countries and is sold through both wholesale (58% of sales) and company-owned channels (42%). In 2025, On generated 58% of its sales in North America, 25% in Europe, the Middle East, and Africa, and 17% in the Asia-Pacific region.
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.